A clinical trial from the University of Bonn found that eating 300 grams of oatmeal daily for just two days significantly reduced LDL cholesterol by 10% in people with metabolic syndrome. The study, published in Nature Communications, compared participants on a calorie-restricted oatmeal diet to a control group that reduced calories without oats. The cholesterol-lowering effects persisted for six weeks after the intervention.

Researchers discovered that oatmeal's benefits extend beyond fiber content. The diet altered gut microbiome composition, increasing bacteria that produce phenolic compounds like ferulic acid, which supports healthy cholesterol metabolism. This mechanism may explain why the intensive oatmeal plan outperformed longer-term moderate oatmeal consumption. The findings revive interest in oats as a therapeutic food, echoing early 20th-century treatments by German physician Carl von Noorden for diabetes patients.

The study involved 68 participants across two randomized controlled trials. While both groups lost weight and saw some health improvements from calorie restriction alone, the oatmeal group experienced substantially greater benefits. Researchers suggest that periodic intensive oatmeal interventions could serve as a well-tolerated approach to maintaining healthy cholesterol levels and preventing diabetes, though longer-term studies are needed to confirm lasting preventative effects.